Singular Genomics Systems Inc
NASDAQ:OMIC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Singular Genomics Systems Inc
Other Long-Term Assets
Singular Genomics Systems Inc
Other Long-Term Assets Peer Comparison
TMO
DHR
MTD
A
IQV
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
Other Long-Term Assets
$1.8m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Long-Term Assets
$4.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
30%
|
CAGR 10-Years
18%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Long-Term Assets
$2.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
32%
|
CAGR 10-Years
9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Long-Term Assets
$358.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Long-Term Assets
$563m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Long-Term Assets
$628m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
See Also
What is Singular Genomics Systems Inc's Other Long-Term Assets?
Other Long-Term Assets
1.8m
USD
Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Other Long-Term Assets amounts to 1.8m USD.
What is Singular Genomics Systems Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
43%
Over the last year, the Other Long-Term Assets growth was -40%. The average annual Other Long-Term Assets growth rates for Singular Genomics Systems Inc have been 43% over the past three years .
You don't have any saved screeners yet
